首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Critical Reviews in Oncogenesis
ISSN：0893-9675

Critical Reviews in Oncogenesis

学科领域：-
是否预警：不在预警名单内
是否OA：否
录用周期：-
新锐分区：-
年发文量：-
影响因子：0
JCR分区：Q0（未被收录）
期刊官网：
投稿链接：

基本信息

-
0893-9675Scopus收录
0
点击查看最新影响趋势>
0
-
新
WOS期刊SCI分区  2024-2025最新升级版
暂无按学科分区信息
暂无h-index数据
-
点击查看年发文量趋势图>
----Biochemistry, Genetics and Molecular Biology-Cancer Research
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
0.00%--
CiteScore：2.00
SJR：0.553
SNIP：0.344
学科类别分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Cancer Research
Q4
185 / 233

期刊高被引文献

Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019031641
Cancer Stem Cells, Their Microenvironment and Anoikis.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2018029433
Computational Biology: Toward Early Detection of Pancreatic Cancer.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019031335
Cancer and Cancer Stem Cells: New Molecular Perspectives.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019029628
Association between Epstein-Barr Virus and Oral Carcinoma: A Systematic Review with Meta-Analysis.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019031897
Cell Signaling Pathways Related to Epithelial Mesenchymal Transition in Cancer Metastasis.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2018029509
Mutualistic Effects of the Myeloid-Derived Suppressor Cells and Cancer Stem Cells in the Tumor Microenvironment.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2018029436
Role of Epstein-Barr Virus in Glioblastoma.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019032655
Obesity, Type-2 Diabetes and Cancer: Mechanistic Insights.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019032959
Nanoparticles in Pancreatic Cancer Imaging and Therapy.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031519
The Possible Interactions and Therapeutic Roles of Lithium Chloride and Midkine on Cancer Treatment.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2018029410
Type 2 Diabetes: An Updated Overview.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019030976
Epstein-Barr Virus and Astrocytoma.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2020032954
Cancer Stem Cells in Urooncology.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019029657
Familial Pancreatic Cancer: A Critical Review.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031637
Recent Advances in Cancer Stem Cell Targeted Therapy.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2018029574
The Role of Oncogenic DNA Viruses in Penile Cancer Development.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2020032961
Treatment of Pediatric Overweight and Obesity: Assessing the Options.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019033037
The Association of Type 2 Diabetes and Site-Specific Cancers: Linking Mechanisms.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019031108
The Importance of Cancer Stem Cells in Gastrointestinal Cancers.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2018029633
DNA Fingerprint Technology: Its Application in Detecting Pancreatic Cancer.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031603
Possible Protective Effects of Thiazolidinediones Antidiabetic Drugs in Colorectal Cancer.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019031265
Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031417
Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019030929
Hyperactivated Insulin Signaling Cascade in Human Glioblastoma Cells.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031365
Newer Trends in Pancreatic Cancer Treatment: Genetic Alterations and the Role of Immune Therapeutic and Targeted Therapies.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031642
Type 2 Diabetes and Cancer: The Nitric Oxide Connection.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019031256
Holistic Approach to Cell Characteristics and Behavioral Analysis.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019029527
Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Oral and Anogenital Carcinogenesis: Potential Tumorigenic Pathways.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2020033071
Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031202
Association between Human Papillomavirus and Epstein-Barr Virus Infections and Cancer of the Uterine Cervix.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/critrevoncog.2019031545
Type 2 Diabetes and Cancer: An Overview of Epidemiological Evidence and Potential Mechanisms.
来源期刊：Critical reviews in oncogenesisDOI：10.1615/CRITREVONCOG.2019031153

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15
论文发表 2-4个月录用 7500+文章录用 不成功可退款